MSD Sweden
About MSD Sweden
"MSD Sverige befinner sig i forskningens framkant för att förebygga och behandla sjukdomar som hotar människor och djur – inklusive cancer, infektionssjukdomar som HIV och Ebola och framväxande djursjukdomar. Vi är cirka 140 medarbetare och vårt kontor ligger i Hagastaden i Stockholm."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
2
Organon and Co
1
Clinical Trials at MSD Sweden
During the past decade, MSD Sweden conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
2015-03-18
2025-05-06
Recruiting
370
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
2015-12-01
2016-10-06
Terminated
2,016
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
2016-11-17
2025-05-30
Recruiting
1,200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MSD Sweden
According to Clinical.Site data, the most researched conditions in "MSD Sweden" are
"Classical Hodgkin Lymphoma" (1 trials), "Contraception" (1 trials), "Lymphoma" (1 trials), "Melanoma" (1 trials) and "Metastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "MSD Sweden" in a lesser frequency.
Clinical Trials Intervention Types at MSD Sweden
Most popular intervention types in "MSD Sweden" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abiraterone acetate 1000 mg" (1 trials), "Belzutifan 120mg" (1 trials), "Carboplatin" (1 trials), "Dexamethasone 8 mg" (1 trials) and "Docetaxel 75 mg/m^2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MSD Sweden
The vast majority of trials in "MSD Sweden" are
1 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at MSD Sweden
Currently, there are NaN active trials in "MSD Sweden".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in MSD Sweden,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MSD Sweden, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".